Increased plasma olfactomedin 2 after interventional therapy is a predictor for restenosis in lower extremity arteriosclerosis obliterans patients

H Li, H Gui, G Yuan, X Zheng, C Gao… - Scandinavian Journal of …, 2018 - Taylor & Francis
Animal studies have indicated that olfactomedin 2 (OLFM2) is involved in the process of
vascular remolding. The aim of the present study was to investigate circulating OLFM2 levels …

Increased plasma olfactomedin 2 after interventional therapy is a predictor for restenosis in lower extremity arteriosclerosis obliterans patients

H Li, H Gui, G Yuan, X Zheng… - … journal of clinical …, 2018 - pubmed.ncbi.nlm.nih.gov
Animal studies have indicated that olfactomedin 2 (OLFM2) is involved in the process of
vascular remolding. The aim of the present study was to investigate circulating OLFM2 levels …

Increased plasma olfactomedin 2 after interventional therapy is a predictor for restenosis in lower extremity arteriosclerosis obliterans patients.

H Li, H Gui, G Yuan, X Zheng, C Gao… - Scandinavian Journal of …, 2018 - europepmc.org
Animal studies have indicated that olfactomedin 2 (OLFM2) is involved in the process of
vascular remolding. The aim of the present study was to investigate circulating OLFM2 levels …